Affimed (AFMD) EBITDA US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, € | ? | -64 006 000 | -64 006 000 | -86 637 000 | -81 473 000 | -102 380 000 | -65 530 000 | ||
Changes by years, y/y, % | +87% | 0% | +35% | -6% | +26% | +40.2% |
Affimed. EBITDA US GAAP, €
Affimed. EBITDA US GAAP, changes, %
Affimed. EBITDA US GAAP, sum by quarters, €
Affimed (AFMD) EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA, € | ? | -19 317 000 | -16 722 000 | -17 065 000 | -14 702 000 | -14 446 000 | -65 530 000 | |
Changes by years, y/y, % | -31% | -49% | -39% | |||||
Changes by quarters, q/q, % | -18% | -13% | +2% | -14% | -2% |